- Home
- CARA vs DOMH Comparison
CARA vs DOMH Comparison
Compare CARA & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARA
- DOMH
- Stock Information
- Founded
- CARA 2004
- DOMH 1967
- Country
- CARA United States
- DOMH United States
- Employees
- CARA N/A
- DOMH N/A
- Industry
- CARA Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- CARA Health Care
- DOMH Health Care
- Exchange
- CARA Nasdaq
- DOMH Nasdaq
- Market Cap
- CARA 15.1M
- DOMH 12.1M
- IPO Year
- CARA 2014
- DOMH N/A
- Fundamental
- Price
- CARA $0.31
- DOMH $1.61
- Analyst Decision
- CARA Hold
- DOMH
- Analyst Count
- CARA 4
- DOMH 0
- Target Price
- CARA $1.00
- DOMH N/A
- AVG Volume (30 Days)
- CARA 818.2K
- DOMH 9.7K
- Earning Date
- CARA 11-26-2024
- DOMH 11-08-2024
- Dividend Yield
- CARA N/A
- DOMH N/A
- EPS Growth
- CARA N/A
- DOMH N/A
- EPS
- CARA N/A
- DOMH N/A
- Revenue
- CARA $10,996,000.00
- DOMH $12,589,000.00
- Revenue This Year
- CARA N/A
- DOMH N/A
- Revenue Next Year
- CARA N/A
- DOMH N/A
- P/E Ratio
- CARA N/A
- DOMH N/A
- Revenue Growth
- CARA N/A
- DOMH 1117.50
- 52 Week Low
- CARA $0.24
- DOMH $1.50
- 52 Week High
- CARA $1.31
- DOMH $3.20
- Technical
- Relative Strength Index (RSI)
- CARA 61.61
- DOMH 40.13
- Support Level
- CARA $0.32
- DOMH $1.52
- Resistance Level
- CARA $0.37
- DOMH $1.69
- Average True Range (ATR)
- CARA 0.03
- DOMH 0.09
- MACD
- CARA 0.00
- DOMH -0.01
- Stochastic Oscillator
- CARA 64.22
- DOMH 32.14
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.